Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy
Title:
Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy
Author:
Guo, Yizhen Wei, Lai Patel, Sandip H. Lopez, Gabrielle Grogan, Madison Li, Mingjia Haddad, Tyler Johns, Andrew Ganesan, Latha P. Yang, Yiping Spakowicz, Daniel J. Shields, Peter G. He, Kai Bertino, Erin M. Otterson, Gregory A. Carbone, David P. Presley, Carolyn Kulp, Samuel K. Mace, Thomas A. Coss, Christopher C. Phelps, Mitch A. Owen, Dwight H.